Kalintis Healthcare is located in Jarod-Vadodara, GJ, India
Located around 2 hours journey by road from Ahmedabad International Airport. Vadodara airport located around 18 Kms. Vadodara city is easily approachable from Mumbai international airport with flying time one hour, located on lush green 11,063 square meters. Kalintis is a state of the art manufacturing facility designed with the latest quality compliance and safety. We are multiplying our efforts and gearing up to build a commercial scale manufacturing operation equipped to handle our challenges.
Technology Development Center is a dedicated Process Development & Analytical Development laboratory which is fully equipped with wide range of process equipment’s & analytical instruments. We have reaction capabilities from Milligram to Kilogram level with systems to utilize the most advanced & safe process for development as per client’s specific requirements.
Our Quality Control laboratory is well equipped with ultra-modern instruments like HPLC, GC, FTIR, UV, Polarimeter, Auto tiltrotor, DSC, Stability Chambers to assure quality standard as per international quality norms. Quality is one of the core focus at Kalintis Healthcare. Stringent quality measures are applied at every step of manufacturing process to get the consistent quality product. GMP compliant facility meeting international regulatory requirements.
Our Dedicated Pilot Plant is catering to produce products ranging from 1 kg to 100 kg/month, having 5 glass lined assembly from 10 to 50 liter in capacity.
Total pilot plant capacity is 1.2 MT/year
Our Intermediate Manufacturing Plant having capacity of 100 kg to 10 MT/ month for producing various fine chemicals, complex molecule, intermediates & having dedicated hydrogenation Manufacturing facility for hydrogenation assisted products.
Total Intermediate plant capacity is 120 MT/year
Our API Manufacturing cGMP Plant is the only one of its kind, having capacity of 5 kg to 16.5 MT/month & going to manufacture wide range of products and adhere to strict regulatory guidelines. The plant shall comply with USFDA 21 CFR Norms of product Manufacturing, International Conference on Harmonization (ICH) guidelines and Schedule M guidelines in the area of Pharma API & Intermediate manufacturing.
Total API plant capacity is 200 MT/year